CaV1.2 voltage-gated calcium channels play critical roles in the control of membrane excitability, gene expression, and muscle contraction. These channels show diverse functional properties generated by alternative splicing at multiple sites within the CaV1.2 pre-mRNA. The molecular mechanisms controlling this splicing are not understood. We find that two exons in the CaV1.2 channel are controlled in part by members of the Fox family of splicing regulators. Exons 9* and 33 confer distinct electrophysiological properties on the channel and show opposite patterns of regulation during cortical development, with exon 9* progressively decreasing its inclusion in the CaV1. CaV1.2 L-type voltage-gated calcium channels are widely distributed in brain, heart, smooth muscle, and endocrine cells and play essential roles in gene expression, muscle contraction, and hormone release (6,13,16,39,47). These channels are composed of three subunits, with the ␣ 1 subunit being the largest and incorporating the conduction pore, the voltage sensor and gating apparatus, as well as sites for channel regulation by second messengers, drugs, and toxins (Fig. 1A) (9,14,17). This CaV1.2 subunit is subject to extensive alternative splicing that generates multiple functionally distinct isoforms (1,29,33,49,62). At least twenty of the 56 exons in the human CaV1.2 transcript are alternatively spliced (29,50,51,55). In particular, alternative exon 9* within the cytoplasmic I-II loop and exon 33 within the IVS3-IVS4 transmembrane segments confer different electrophysiological and pharmacological properties on the channel and exhibit tissue-specific differences in inclusion (30,31,54,55). Changes in exon 9* (also named exon 9A) splicing are seen in human arterial smooth muscle cells that have developed atherosclerosis (57) and in hypertrophied cardiomyocytes of spontaneously hypertensive rats (56). Alternative exons 9* and 33 are conserved across vertebrate species demonstrating their functional importance to the CaV1.2 channel. However, the molecular mechanisms controlling their splicing have not been studied.Members of the Fox protein family, homologs of the Feminizing on the X gene product from Caenorhabditis elegans (21,41,48), regulate the splicing of many neuron-and musclespecific splicing events (22,40,59,(63)(64)(65)(66). There are three mammalian family members, Fox1 (A2BP1), Fox2 (RBM9), and Fox3 (hnrbp3), each containing a nearly identical RNAbinding domain that recognizes the hexanucleotide element UGCAUG (2). These proteins bind the introns adjacent to their target exons where they generally repress splicing when bound upstream of the exon but enhance splicing from a downstream binding site (22,40,59,63,64,66). In addition to the RNA-binding domain, all three proteins have similar N and C-terminal domains that are extensively modified by alternative promoter use and alternative splicing to produce a large family of related proteins. Fox1 is expressed in neurons and muscle, and Fox3 is expressed only in neurons (22,23,36,59). Fox2 show...